Literature DB >> 12041879

External quality assurance program for biological monitoring in occupational and environmental medicine.

K H Schaller1, J Angerer, D Weltle, H Drexler.   

Abstract

Biological monitoring of chemical exposure in the workplace and in the environment has become increasingly important in assessing health risk. The analysis must be carried out under a quality assurance scheme to guarantee that the results obtained in biological monitoring are comparable with the threshold limit values and results from other laboratories. Since 1982, the German Society for Occupational and Environmental Medicine has offered 28 intercomparison programs. These programs cover 96 analytes in urine, blood, and plasma for 47 substances and cover most parameters that are relevant in occupational and environmental medicine. The data obtained in these programs provide a good overview of the current quality of the determination of analytes that are assessed in occupational and environmental toxicological laboratories. For the analyses of inorganic substances in blood and urine, the tolerable variation ranges from 7.5% to 43.5%. For organic substances in urine, the tolerable variation ranges from 12% to 48%. For organic substances in urine, the tolerable variation ranges from 12% to 48%. The highest variations (36% to 60%) were found for the analysis of organochlorine compounds in plasma. The tolerable variations for determining solvents in blood by head space gas chromatography range from 26% to 57%. The overall average success rates for the participants of the external quality programs range from 65% to 75%.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 12041879     DOI: 10.1515/reveh.2001.16.4.223

Source DB:  PubMed          Journal:  Rev Environ Health        ISSN: 0048-7554            Impact factor:   3.458


  1 in total

1.  Useful and Fast Method for Blood Lead and Cadmium Determination Using ICP-MS and GF-AAS; Validation Parameters.

Authors:  Malgorzata Trzcinka-Ochocka; Renata Brodzka; Beata Janasik
Journal:  J Clin Lab Anal       Date:  2014-11-25       Impact factor: 2.352

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.